Variant report

Variant	nsv911755
Chromosome Location	chr19:41354629-41392885
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:365)
CpG islands
(count:549)
Chromatin interactive
region (count:3)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:365 , 50 per page) page: 1 2 3 4 5 6 7 8

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr19:41370633-41370945	K562	blood:	n/a	n/a
2	ARID3A	chr19:41378197-41378436	K562	blood:	n/a	n/a
3	ATF1	chr19:41370536-41370948	K562	blood:	n/a	n/a
4	ATF1	chr19:41378237-41378485	K562	blood:	n/a	n/a
5	ATF3	chr19:41370620-41370877	K562	blood:	n/a	n/a
6	ATF3	chr19:41378141-41378430	K562	blood:	n/a	n/a
7	CBX3	chr19:41379821-41380148	K562	blood:	n/a	n/a
8	CBX3	chr19:41381255-41381833	K562	blood:	n/a	n/a
9	CBX3	chr19:41379769-41380227	K562	blood:	n/a	n/a
10	CBX3	chr19:41370123-41371107	K562	blood:	n/a	n/a
11	CCNT2	chr19:41370582-41370786	K562	blood:	n/a	n/a
12	CEBPB	chr19:41370209-41371189	K562	blood:	n/a	chr19:41370433-41370441
13	CEBPB	chr19:41367289-41367476	A549	lung:	n/a	n/a
14	CEBPB	chr19:41373834-41374300	A549	lung:	n/a	n/a
15	CEBPB	chr19:41370543-41370910	K562	blood:	n/a	n/a
16	CEBPB	chr19:41374056-41374100	A549	lung:	n/a	n/a
17	CEBPB	chr19:41368480-41368982	A549	lung:	n/a	n/a
18	CEBPB	chr19:41373920-41374208	K562	blood:	n/a	n/a
19	CEBPB	chr19:41378139-41378466	K562	blood:	n/a	n/a
20	CEBPB	chr19:41362024-41362201	K562	blood:	n/a	n/a
21	CEBPB	chr19:41370305-41370801	K562	blood:	n/a	chr19:41370433-41370441
22	CEBPB	chr19:41378202-41378474	K562	blood:	n/a	n/a
23	CEBPB	chr19:41368761-41369068	Hela-S3	cervix:	n/a	n/a
24	CEBPB	chr19:41368416-41368601	K562	blood:	n/a	n/a
25	CEBPD	chr19:41370295-41371143	K562	blood:	n/a	n/a
26	CEBPD	chr19:41370661-41370862	K562	blood:	n/a	n/a
27	CEBPD	chr19:41392214-41392550	K562	blood:	n/a	n/a
28	CTCF	chr19:41354510-41354631	Medullo	brain:	n/a	n/a
29	CTCF	chr19:41354520-41354670	HUVEC	blood vessel:	n/a	n/a
30	CTCF	chr19:41368500-41368650	NHLF	lung:	n/a	n/a
31	CTCF	chr19:41354520-41354670	HRE	kidney:	n/a	n/a
32	CTCF	chr19:41368300-41368450	MCF-7	breast:	n/a	n/a
33	CTCF	chr19:41354488-41354703	IMR90	lung:	n/a	n/a
34	CTCF	chr19:41354520-41354670	AG04449	skin:	n/a	n/a
35	CTCF	chr19:41364158-41364220	MCF-7	breast:	n/a	n/a
36	CTCF	chr19:41354520-41354670	SAEC	small airway:	n/a	n/a
37	CTCF	chr19:41386312-41386552	H1-hESC	embryonic stem cell:	n/a	n/a
38	CTCF	chr19:41368380-41368530	NHEK	skin:	n/a	n/a
39	CTCF	chr19:41388830-41388853	LNCaP	prostate:	n/a	n/a
40	CTCF	chr19:41354345-41354814	H1-hESC	embryonic stem cell:	n/a	chr19:41354699-41354709
41	CTCF	chr19:41364147-41364298	K562	blood:	n/a	n/a
42	CTCF	chr19:41354500-41354650	HCM	heart:	n/a	n/a
43	CTCF	chr19:41386211-41386665	K562	blood:	n/a	n/a
44	CTCF	chr19:41354660-41354810	A549	lung:	n/a	chr19:41354699-41354709
45	CTCF	chr19:41354500-41354650	AG04449	skin:	n/a	n/a
46	CTCF	chr19:41367560-41367710	HEK293	kidney:	n/a	n/a
47	CTCF	chr19:41354520-41354670	WERI-Rb-1	eye:	n/a	n/a
48	CTCF	chr19:41354540-41354690	AG04450	lung:	n/a	n/a
49	CTCF	chr19:41354520-41354670	HEK293	kidney:	n/a	n/a
50	CTCF	chr19:41364037-41364460	MCF-7	breast:	n/a	n/a

(count:549 , 50 per page) page: 1 2 3 4 5 6 7 ... 11

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr19:41354682-41354732	T-47D	breast:	n/a
2	chr19:41354682-41354732	AoSMC	blood vessel:	n/a
3	chr19:41386507-41386557	BE2_C	brain:	n/a
4	chr19:41388232-41388282	HCM	heart:	n/a
5	chr19:41354682-41354732	GM19239	blood:	n/a
6	chr19:41388384-41388434	HepG2	liver:	n/a
7	chr19:41386507-41386557	HPAEpiC	pulmonary alveolar:	n/a
8	chr19:41355973-41356023	Hela-S3	cervix:	n/a
9	chr19:41354682-41354732	HL-60	blood:	n/a
10	chr19:41388384-41388434	PrEC	prostate:	n/a
11	chr19:41385865-41385915	NHDF-neo	bronchial:	n/a
12	chr19:41386441-41386491	SK-N-MC	brain:	n/a
13	chr19:41383654-41383704	SK-N-SH_RA	brain:	n/a
14	chr19:41386441-41386491	HPAEpiC	pulmonary alveolar:	n/a
15	chr19:41388232-41388282	HCT-116	colon:	n/a
16	chr19:41383654-41383704	HEK293	kidney:	embryo
17	chr19:41385865-41385915	NHBE	bronchial:	n/a
18	chr19:41383654-41383704	HPAEpiC	pulmonary alveolar:	n/a
19	chr19:41388384-41388434	GM06990	blood:	n/a
20	chr19:41354682-41354732	HRE	kidney:	n/a
21	chr19:41355973-41356023	AG09319	gingival:	n/a
22	chr19:41383654-41383704	U87	brain:	n/a
23	chr19:41355973-41356023	MCF10A-Er-Src	breast:	n/a
24	chr19:41383654-41383704	HNPCEpiC	eye:	n/a
25	chr19:41354682-41354732	HRCEpiC	kidney:	n/a
26	chr19:41386441-41386491	BE2_C	brain:	n/a
27	chr19:41386507-41386557	ovcar-3	ovarian:	n/a
28	chr19:41385865-41385915	HPAEpiC	pulmonary alveolar:	n/a
29	chr19:41383654-41383704	NH-A	brain:	n/a
30	chr19:41386507-41386557	CMK	blood:	n/a
31	chr19:41385865-41385915	CMK	blood:	n/a
32	chr19:41355973-41356023	PFSK-1	brain:	n/a
33	chr19:41388232-41388282	NB4	blood:	n/a
34	chr19:41386507-41386557	U87	brain:	n/a
35	chr19:41383654-41383704	HCM	heart:	n/a
36	chr19:41388232-41388282	MCF-7	breast:	n/a
37	chr19:41354682-41354732	HAEpiC	amniotic membrane:	n/a
38	chr19:41386507-41386557	Hela-S3	cervix:	n/a
39	chr19:41385865-41385915	Jurkat	blood:	n/a
40	chr19:41355973-41356023	A549	lung:	n/a
41	chr19:41385865-41385915	MCF-7	breast:	n/a
42	chr19:41355973-41356023	MCF-7	breast:	n/a
43	chr19:41386507-41386557	NHBE	bronchial:	n/a
44	chr19:41388232-41388282	HIPEpiC	eye:	n/a
45	chr19:41354682-41354732	Jurkat	blood:	n/a
46	chr19:41386507-41386557	Hepatocyte	liver:	n/a
47	chr19:41385865-41385915	GM19239	blood:	n/a
48	chr19:41385865-41385915	SK-N-MC	brain:	n/a
49	chr19:41389684-41389734	HAEpiC	amniotic membrane:	n/a
50	chr19:41388384-41388434	AG09309	skin:	n/a

(count:3 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr19:41195484..41197379-chr19:41368669..41371255,2	K562	blood:
2	chr19:41369230..41371017-chr19:41372027..41374078,2	K562	blood:
3	chr19:41369230..41371017-chr19:41372027..41374078,2	K562	blood:

No data

Variant related genes	Relation type
CYP2G1P	TF binding region
CYP2A6	TF binding region
CYP2A7	TF binding region
CYP2G1P	CpG island
CYP2A6	CpG island
CYP2A7	CpG island
ENSG00000105245	chromatin interactions

Extended variants
information (count: 2008 )
Associated
traits (count: 64 )

Variant overlapped rSNPs/rCNVs (count:2008 , 50 per page) page: 1 2 3 4 5 6 7 ... 41

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs4986891	chr19:41354629-41354630	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
2	rs537280653	chr19:41354634-41354635	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
3	rs373566142	chr19:41354639-41354640	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
4	rs61562160	chr19:41354651-41354652	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
5	rs28399440	chr19:41354660-41354661	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
6	rs79584535	chr19:41354661-41354662	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
7	rs376782364	chr19:41354666-41354667	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
8	rs72547583	chr19:41354669-41354670	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
9	rs577758165	chr19:41354682-41354683	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Enhancers	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
10	rs148803816	chr19:41354688-41354689	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Enhancers	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
11	rs201873185	chr19:41354689-41354690	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Enhancers	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
12	rs371146023	chr19:41354699-41354700	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Enhancers	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
13	rs200390640	chr19:41354702-41354703	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Enhancers	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
14	rs572417875	chr19:41354704-41354705	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Enhancers	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
15	rs8192725	chr19:41354712-41354713	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Enhancers	TF binding region CpG island	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
16	rs561651970	chr19:41354726-41354727	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Enhancers	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
17	rs370272750	chr19:41354731-41354732	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Enhancers	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
18	rs567115644	chr19:41354733-41354734	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
19	rs531895004	chr19:41354773-41354774	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
20	rs531139871	chr19:41354780-41354781	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
21	rs549252695	chr19:41354798-41354799	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
22	rs72549438	chr19:41354846-41354847	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
23	rs548652766	chr19:41354873-41354874	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
24	rs71173689	chr19:41354881-41354882	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
25	rs368499260	chr19:41354931-41354932	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
26	rs71358939	chr19:41354940-41354941	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
27	rs200110220	chr19:41354941-41354942	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
28	rs201245811	chr19:41354942-41354943	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
29	rs60164957	chr19:41354950-41354951	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
30	rs184320279	chr19:41354985-41354986	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
31	rs72549437	chr19:41354993-41354994	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
32	rs114114578	chr19:41355008-41355009	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
33	rs565605333	chr19:41355024-41355025	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
34	rs536267403	chr19:41355055-41355056	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
35	rs547855533	chr19:41355065-41355066	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
36	rs569969411	chr19:41355066-41355067	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
37	rs536649338	chr19:41355079-41355080	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
38	rs148948768	chr19:41355120-41355121	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
39	rs368293122	chr19:41355127-41355128	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
40	rs576524900	chr19:41355176-41355177	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
41	rs534449205	chr19:41355181-41355182	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
42	rs553928000	chr19:41355184-41355185	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
43	rs7250713	chr19:41355195-41355196	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer Active TSS Weak transcription	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
44	rs543272794	chr19:41355209-41355210	Bivalent Enhancer Enhancers Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
45	rs76834270	chr19:41355230-41355231	Bivalent Enhancer Enhancers Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
46	rs74654301	chr19:41355236-41355237	Bivalent Enhancer Enhancers Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
47	rs554973769	chr19:41355259-41355260	Bivalent Enhancer Enhancers Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
48	rs528420546	chr19:41355268-41355269	Bivalent Enhancer Enhancers Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
49	rs547078508	chr19:41355291-41355292	Bivalent Enhancer Enhancers Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
50	rs543835444	chr19:41355299-41355300	Bivalent Enhancer Enhancers Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:64)

Disease	PMID	Source
Myelodysplastic syndrome	17634407	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Chordoma	21602918	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Cancer	21637783	CNVD
Retinoblastoma	21504564	CNVD
Medulloblastoma	21979893	CNVD
Ovarian cancer	21720365	CNVD
Cancer	20164919	CNVD
Thoracic aortic aneurysm	21092924	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Prostate cancer	18632612	CNVD
Autism	22495311	CNVD
Adenoid cystic carcinoma	18698036	CNVD
Ductal carcinoma	22052326	CNVD
Congenital nephrotic syndrome	18421352	CNVD
Astrocytoma	17934521	CNVD
Leukemia	17361228	CNVD
Adenoid cystic carcinoma	17372589	CNVD
Breast cancer	21858162	CNVD
Breast cancer	17603634	CNVD
Glioma	21971842	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Endometrial cancer	22040021	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	21264507	CNVD
Oligodendroglial tumors	17285580	CNVD
renal disease	20603712	CNVD
Salivary gland adenoid cystic carcinoma	17545515	CNVD
Ovarian cancer	22174824	CNVD
Breast cancer	16608533	CNVD
Neuroblastoma	18923191	CNVD
Breast cancer	21364760	CNVD
Invasive pancreatic ductal carcinoma	18765526	CNVD
Rhabdomyosarcoma	16790082	CNVD
Chordoma	18071362	CNVD
Urothelial carcinoma	21177765	CNVD
small cell lung cancer	20016488	CNVD
Wilms tumour	21544195	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Ovarian neoplasms	16753589	CNVD
Malignant fibrous histiocytomas	21085701	CNVD
Metanephric adenoma	20802469	CNVD
Acute myeloid leukemia	16864856	CNVD
Bladder cancer	21909424	CNVD
Medulloblastoma	16783165	CNVD
Gastric cancer	18160780	CNVD
Hepatocellular carcinoma	16750200	CNVD
Basal cell lymphoma	19029149	CNVD
Breast cancer	20409316	CNVD
Diffuse large b-cell lymphoma	19029149	CNVD
Multiple myeloma	16616336	CNVD
Renal cell carcinoma	18765545	CNVD
Acute myeloid leukemia	20729466	CNVD
Lung cancer	18438408	CNVD
Genital abnormality	22378287	CNVD
Hypospadia	22378287	CNVD
Ovarian clear cell carcinoma	19293255	CNVD
Astrocytoma	22246337	CNVD
Non-syndromic sensorineural hearing loss	21293372	CNVD
Pancreatic cancer	17952125	CNVD
Breast cancer	22522925	CNVD

Chromatin state (count:246 , 50 per page) page: 1 2 3 4 5

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr19:41353600-41354800	Enhancers	Lung	lung
2	chr19:41353800-41354800	Bivalent Enhancer	Breast Myoepithelial Primary Cells	Breast
3	chr19:41354000-41354800	Enhancers	Spleen	Spleen
4	chr19:41354200-41354800	Bivalent/Poised TSS	HUES64 Cell Line	embryonic stem cell
5	chr19:41354200-41354800	Bivalent/Poised TSS	iPS-15b Cell Line	embryonic stem cell
6	chr19:41354200-41354800	Bivalent/Poised TSS	iPS-18 Cell Line	embryonic stem cell
7	chr19:41354200-41354800	Enhancers	Primary Natural Killer cells fromperipheralblood	blood
8	chr19:41354200-41355000	Bivalent/Poised TSS	H9 Cell Line	embryonic stem cell
9	chr19:41354200-41355000	Bivalent/Poised TSS	HUES6 Cell Line	embryonic stem cell
10	chr19:41354400-41354800	Bivalent/Poised TSS	HUES48 Cell Line	embryonic stem cell
11	chr19:41354400-41354800	Bivalent/Poised TSS	iPS DF 6.9 Cell Line	embryonic stem cell
12	chr19:41354400-41354800	Active TSS	ES-UCSF4 Cell Line	embryonic stem cell
13	chr19:41354400-41354800	Flanking Bivalent TSS/Enh	Primary T cells fromperipheralblood	blood
14	chr19:41354400-41354800	Flanking Active TSS	Primary T helper naive cells fromperipheralblood	blood
15	chr19:41354400-41354800	Bivalent Enhancer	Foreskin Melanocyte Primary Cells skin03	Skin
16	chr19:41354400-41354800	Active TSS	Brain Angular Gyrus	brain
17	chr19:41354400-41354800	Enhancers	Brain Hippocampus Middle	brain
18	chr19:41354400-41354800	Active TSS	Brain Inferior Temporal Lobe	brain
19	chr19:41354400-41354800	Bivalent Enhancer	Fetal Adrenal Gland	Adrenal Gland
20	chr19:41354400-41354800	Bivalent Enhancer	Fetal Muscle Trunk	muscle
21	chr19:41354400-41354800	Enhancers	Gastric	stomach
22	chr19:41354400-41354800	Enhancers	Pancreas	Pancrea
23	chr19:41354400-41354800	Enhancers	Right Atrium	heart
24	chr19:41354400-41355000	Bivalent/Poised TSS	H1 Cell Line	embryonic stem cell
25	chr19:41354400-41355000	Bivalent/Poised TSS	iPS-20b Cell Line	embryonic stem cell
26	chr19:41354400-41355000	Flanking Bivalent TSS/Enh	Primary hematopoietic stem cells G-CSF-mobilized Female	--
27	chr19:41354400-41355000	Flanking Bivalent TSS/Enh	Primary hematopoietic stem cells G-CSF-mobilized Male	--
28	chr19:41354400-41355000	Enhancers	Adipose Nuclei	Adipose
29	chr19:41354400-41355000	Bivalent/Poised TSS	A549	lung
30	chr19:41354400-41355200	Bivalent/Poised TSS	ES-I3 Cell Line	embryonic stem cell
31	chr19:41354400-41355200	Enhancers	Primary T helper naive cells from peripheral blood	blood
32	chr19:41354400-41355200	Enhancers	Primary T helper 17 cells PMA-I stimulated	--
33	chr19:41354400-41355400	Enhancers	Primary T killer naive cells fromperipheralblood	blood
34	chr19:41354400-41355600	Enhancers	Primary T helper memory cells from peripheral blood 1	blood
35	chr19:41354600-41354800	Bivalent/Poised TSS	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
36	chr19:41354600-41354800	Flanking Bivalent TSS/Enh	IMR90 fetal lung fibroblasts Cell Line	lung
37	chr19:41354600-41354800	Flanking Active TSS	iPS DF 19.11 Cell Line	embryonic stem cell
38	chr19:41354600-41354800	Bivalent Enhancer	Primary neutrophils fromperipheralblood	blood
39	chr19:41354600-41354800	Bivalent Enhancer	Primary T regulatory cells fromperipheralblood	blood
40	chr19:41354600-41354800	Flanking Active TSS	Primary T cells effector/memory enriched fromperipheralblood	blood
41	chr19:41354600-41354800	Active TSS	Primary T killer memory cells from peripheral blood	blood
42	chr19:41354600-41354800	Flanking Bivalent TSS/Enh	Foreskin Fibroblast Primary Cells skin01	Skin
43	chr19:41354600-41354800	Flanking Bivalent TSS/Enh	Foreskin Fibroblast Primary Cells skin02	Skin
44	chr19:41354600-41354800	Bivalent Enhancer	Foreskin Melanocyte Primary Cells skin01	Skin
45	chr19:41354600-41354800	Enhancers	Brain Anterior Caudate	brain
46	chr19:41354600-41354800	Bivalent Enhancer	Colon Smooth Muscle	Colon
47	chr19:41354600-41354800	Bivalent Enhancer	Fetal Stomach	stomach
48	chr19:41354600-41354800	Flanking Active TSS	Rectal Smooth Muscle	rectum
49	chr19:41354600-41354800	Bivalent Enhancer	Monocytes-CD14+_RO01746	blood
50	chr19:41354600-41355000	Enhancers	Primary hematopoietic stem cells	blood

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links